These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36981781)

  • 21. Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis.
    Takekawa T; Abo M; Ebihara K; Taguchi K; Sase Y; Kakuda W
    Acta Neurol Belg; 2013 Dec; 113(4):469-75. PubMed ID: 23716062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT; Yu HK; Chen LR; Chang CN; Chen YM; Hu GC
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2143-2150. PubMed ID: 30392753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.
    Lee JM; Gracies JM; Park SB; Lee KH; Lee JY; Shin JH
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30366407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.
    Chang CL; Munin MC; Skidmore ER; Niyonkuru C; Huber LM; Weber DJ
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1462-8. PubMed ID: 19735772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin a, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study.
    Levy CE; Giuffrida C; Richards L; Wu S; Davis S; Nadeau SE
    Am J Phys Med Rehabil; 2007 Sep; 86(9):696-706. PubMed ID: 17709993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report.
    Amano S; Takebayashi T; Hanada K; Umeji A; Marumoto K; Furukawa K; Domen K
    Phys Ther; 2015 Jul; 95(7):1039-45. PubMed ID: 25592185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attempting to improve function and quality of life using the FTM Protocol: case report.
    Butler A; Blanton S; Rowe V; Wolf S
    J Neurol Phys Ther; 2006 Sep; 30(3):148-56. PubMed ID: 17029658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke.
    Sun SF; Hsu CW; Hwang CW; Hsu PT; Wang JL; Yang CL
    Phys Ther; 2006 Oct; 86(10):1387-97. PubMed ID: 17012643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
    Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Distributed vs. Condensed Schedule for Robot-Assisted Training with Botulinum Toxin A Injection for Spastic Upper Limbs in Chronic Post-Stroke Subjects.
    Hung JW; Chen YW; Chen YJ; Pong YP; Wu WC; Chang KC; Wu CY
    Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.